The documents indicated Mortimer D.A. Sackler emailed two other directors in the company that the pharmaceutical industry “had become far too volatile and risky” for the family to invest nearly all of its wealth in. The revelation suggests that the Sacklers had long been concerned about the financial risks of keeping its ownership stake in a drug company.
The newly released complaint, filed previously by the Connecticut attorney general against Purdue Pharma and some of the Sacklers, is one of the more than 1,600 lawsuits Purdue Pharma faces for its alleged role in fueling the opioid crisis in the U.S.
Read the full report here.
More articles on pharmacy:
Insys execs guilty of opioid racketeering scheme
Walgreens shaking up C-suite
Generic drugmakers could thrive in a recession, Moody’s says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
